4-chloro-3-hydroxybutyric acid: structure in first source [MeSH]
ID Source | ID |
---|---|
PubMed CID | 10129995 |
SCHEMBL ID | 374298 |
MeSH ID | M0499389 |
Synonym |
---|
95574-97-3 |
SCHEMBL374298 |
26329-66-8 |
butanoic acid, 4-chloro-3-hydroxy- |
4-chloro-3-hydroxybutyric acid |
4-chloro-3-hydroxybutanoic acid |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3-hydroxybutyric acid | (omega-1)-hydroxy fatty acid; 3-hydroxy monocarboxylic acid; hydroxybutyric acid | human metabolite | 2015 | 2015 | 9.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
4-butyrolactone | butan-4-olide | metabolite; neurotoxin | 2006 | 2006 | 18.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | |
butyramide | butanamides; primary fatty amide | 2008 | 2008 | 16.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | ||
ethyl 4-chloro-3-oxobutanoate | 2015 | 2016 | 8.5 | high | 0 | 0 | 0 | 0 | 2 | 0 | |||
3,4-dihydroxybutanoic acid gamma-lactone | 2006 | 2006 | 18.0 | high | 0 | 0 | 0 | 1 | 0 | 0 | |||
nadp | 2015 | 2020 | 6.5 | high | 0 | 0 | 0 | 0 | 2 | 0 |
Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|